BNTC Benitec Biopharma Inc.

Fundamentals / CIK 0001808898 / USD

Benitec Biopharma Inc. reported $179.1M in total assets and a net loss of $49.51M through June 30, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BNTC in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2019 to 2026), reported in USD.

$16.83M$8.42M$0-$43.62MFY 2019 Revenue: $12.20MFY 2019 Net Income: $2.61M2019FY 2020 Revenue: $102KFY 2020 Net Income: -$8.27M2020FY 2021 Revenue: $59KFY 2021 Net Income: -$13.88M2021FY 2022 Revenue: $73KFY 2022 Net Income: -$18.21M2022FY 2023 Revenue: $75KFY 2023 Net Income: -$19.56M2023FY 2024 Revenue: $0FY 2024 Net Income: -$21.75M2024FY 2025 Net Income: -$37.92M2025FY 2026 Net Income: -$45.55M2026

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Jun 30 Jun 30 Jun 30 Jun 30 Jun 30 Jun 30 Jun 30 Jun 30
Revenue -- -- $0 $75K $73K $59K $102K $12.20M
Research & Development $23.39M $18.33M $15.61M $12.77M $11.27M $7.02M $3.00M $4.57M
Total Operating Expenses $51.19M $41.77M $22.49M $19.16M $17.93M $13.65M $8.38M $9.62M
Operating Income -$51.19M -$41.77M -$22.49M -$19.08M -$17.85M -$13.60M -$8.28M $2.58M
EBITDA -$51.13M -$41.70M -$22.40M -$18.95M -$17.69M -$13.37M -$8.09M $2.74M
Income Tax Expense $0 -- -- -- -- -- -- --
Net Income -$45.55M -$37.92M -$21.75M -$19.56M -$18.21M -$13.88M -$8.27M $2.61M
Basic EPS -$0.98 -$1.05 -$1.22 -$0.03 -$0.07 -$0.10 -$0.26 $0.10
Diluted EPS -$0.98 -$1.05 -$1.22 -$0.03 -$0.07 -$0.10 -$0.26 $0.10
Basic Shares Outstanding 46.6M 36.2M 18.4M 745.0M 258.4M 135.8M 32.3M 27.1M
Diluted Shares Outstanding 46.6M 36.2M 18.4M 745.0M 258.4M 135.8M 32.3M 27.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- $0 $0 $0 -- $0 $0
Research & Development $8.62M $7.89M $6.30M $5.83M $3.37M $2.87M $6.50M $5.38M
Total Operating Expenses $14.48M $14.43M $13.58M $13.38M $9.80M $9.83M $15.34M $10.80M
Operating Income -$14.48M -$14.43M -$13.58M -$13.38M -$9.80M -$9.83M -$15.34M -$10.80M
EBITDA -$14.46M -$14.41M -$13.57M -$13.36M -$9.79M -$9.82M -$15.32M -$10.79M
Net Income -$12.93M -$12.81M -$11.94M -$11.84M -$8.96M -$8.80M -$14.50M -$9.55M
Basic EPS -$0.26 -- -$0.24 -$0.26 -$0.22 -$0.21 -$0.38 -$0.26
Diluted EPS -$0.26 -- -$0.24 -$0.26 -$0.22 -$0.21 -$0.38 -$0.26
Basic Shares Outstanding 49.5M -- 49.4M 46.0M 41.5M 41.2M 38.6M 37.3M
Diluted Shares Outstanding 49.5M -- 49.4M 46.0M 41.5M 41.2M 38.6M 37.3M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Jun 30 Jun 30 Jun 30 Jun 30 Jun 30 Jun 30 Jun 30 Jun 30
Cash & Cash Equivalents $180.0M $97.74M $50.87M $2.48M $4.06M $19.77M $9.80M $15.72M
Cash & Short-Term Investments $180.0M $97.74M $50.87M $2.48M $4.06M $19.77M $9.80M $15.72M
Other Current Assets $1.59M $628K $516K $1.18M $741K $799K $949K $502K
Total Current Assets $181.7M $98.52M $51.67M $3.73M $4.82M $20.61M $10.81M $18.76M
Property, Plant & Equipment, Net $178K $131K $179K $87K $222K $375K $374K $470K
Other Non-Current Assets $12K $28K $62K $97K $135K $185K -- --
Total Non-Current Assets $938K $1.07M $536K $735K $1.15M $771K $778K $479K
Total Assets $182.6M $99.59M $52.21M $4.46M $5.97M $21.38M $11.59M $19.23M
Accounts Payable $913K $201K $1.35M $1.14M $422K $274K $282K $1.47M
Total Current Liabilities $5.34M $1.80M $4.92M $3.98M $2.53M $1.37M $1.14M $2.64M
Total Non-Current Liabilities $266K $495K $38K $284K $559K $0 $213K $0
Total Liabilities $5.61M $2.30M $4.96M $4.26M $3.09M $1.37M $1.35M $2.64M
Total Debt (incl. Leases) $762K $849K $284K $559K $811K $213K $405K --
Common Stock $3.0K $2.0K $1.0K $0 $0 $1.0K $0 $1.0K
Retained Earnings -$273.7M -$228.2M -$190.3M -$167.9M -$148.3M -$130.1M -$116.6M -$108.9M
Accumulated Other Comp. Income -$963K -$839K -$892K -$830K -$1.25M -$1.46M -$1.95M -$1.86M
Total Stockholders' Equity $177.0M $97.30M $47.25M $202K $2.88M $20.01M $10.24M $16.59M
Total Equity $177.0M $97.30M $47.25M $202K $2.88M $20.01M $10.24M $16.59M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $176.4M $180.0M $184.8M $188.8M $94.48M $97.74M $103.6M $78.28M
Cash & Short-Term Investments $176.4M $180.0M $184.8M $188.8M $94.48M $97.74M $103.6M $78.28M
Other Current Assets $1.62M $1.59M $1.14M $562K $480K $628K $361K $366K
Total Current Assets $178.1M $181.7M $186.0M $189.6M $95.08M $98.52M $104.0M $78.71M
Property, Plant & Equipment, Net $110K $178K $116K $115K $118K $131K $145K $151K
Other Non-Current Assets $244K $12K $12K $11K $20K $28K $35K $42K
Total Non-Current Assets $994K $938K $983K $1.09M $948K $1.07M $1.20M $355K
Total Assets $179.1M $182.6M $187.0M $190.7M $96.03M $99.59M $105.2M $79.07M
Accounts Payable $1.02M $913K $635K $1.02M $271K $201K $433K $593K
Total Current Liabilities $9.08M $5.34M $3.27M $2.80M $2.02M $1.80M $7.03M $3.09M
Total Non-Current Liabilities $374K $266K $394K $519K $403K $495K $613K $38K
Total Liabilities $9.45M $5.61M $3.67M $3.32M $2.43M $2.30M $7.64M $3.13M
Total Debt (incl. Leases) $642K $762K $876K $987K $817K $849K $959K $137K
Common Stock $4.0K $3.0K $3.0K $3.0K $2.0K $2.0K $2.0K $2.0K
Retained Earnings -$286.6M -$273.7M -$260.9M -$249.0M -$237.1M -$228.2M -$212.0M -$202.7M
Accumulated Other Comp. Income -$947K -$963K -$952K -$883K -$750K -$839K -$716K -$688K
Total Stockholders' Equity $169.6M $177.0M $183.3M $187.4M $93.60M $97.30M $97.57M $75.94M
Total Equity $169.6M $177.0M $183.3M $187.4M $93.60M $97.30M $97.57M $75.94M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Jun 30 Jun 30 Jun 30 Jun 30 Jun 30 Jun 30 Jun 30 Jun 30
Net Income -$45.55M -$37.92M -$21.75M -$19.56M -$18.21M -$13.88M -$8.27M $2.61M
Depreciation & Amortization $58K $66K $87K $136K $167K $231K $190K $158K
Stock-Based Compensation $26.41M $17.43M $830K $452K $870K $634K $237K $672K
Operating Cash Flow -$16.52M -$23.59M -$19.40M -$18.01M -$15.90M -$12.83M -$7.54M $4.79M
Capital Expenditure -$105K -$18K -$179K -$1.0K -$13K -$221K -$95K -$404K
Free Cash Flow -$16.62M -$23.61M -$19.58M -$18.01M -$15.91M -$13.05M -$7.63M $4.39M
Investing Cash Flow -$105K -$18K -$179K -$1.0K -$13K -$221K -$94K -$400K
Common Stock Issued $104.5M $30.46M -- $17.88M -- $25.75M $2.25M --
Financing Cash Flow $98.98M $70.48M $68.03M $16.02M -- $22.52M $1.77M --
Net Change in Cash $82.23M $46.93M $48.44M -$1.59M -$15.71M $9.97M -- --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$12.93M -$12.81M -$11.94M -$11.84M -$8.96M -$8.80M -$14.50M -$9.55M
Depreciation & Amortization $17K $17K $14K $14K $13K $14K $13K $14K
Stock-Based Compensation $5.51M $6.26M $7.59M $7.38M $5.18M $6.11M $7.74M $3.14M
Operating Cash Flow -$3.62M -$4.94M -$4.45M -$3.78M -$3.35M -$8.21M -$3.09M -$7.70M
Investing Cash Flow $0 -$79K -$15K -$11K $0 $0 -$6.0K -$12K
Financing Cash Flow $0 $241K $506K $98.23M $0 $2.74M $28.21M $17.87M
Net Change in Cash -$3.60M -$4.79M -$4.03M $94.31M -$3.27M -$5.59M $25.10M $10.44M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Jun 30 Jun 30 Jun 30 Jun 30 Jun 30 Jun 30 Jun 30 Jun 30
Operating Margin -- -- -- -25441.3% -24457.5% -23044.1% -8118.6% 21.2%
Net Profit Margin -- -- -- -26082.7% -24942.5% -23528.8% -8111.8% 21.4%
Return on Equity (ROE) -25.7% -39.0% -46.0% -9684.2% -631.8% -69.4% -80.8% 15.7%
Return on Assets (ROA) -24.9% -38.1% -41.7% -438.2% -304.8% -64.9% -71.4% 13.6%
Current Ratio 34.00x 54.67x 10.49x 0.94x 1.90x 15.05x 9.51x 7.10x
Quick Ratio 33.68x 54.24x 10.33x 0.62x 1.60x 14.44x 8.63x 5.95x
Debt to Equity 0.00x 0.01x 0.01x 2.77x 0.28x 0.01x 0.04x --
Revenue Growth (YoY) -- -- -100.0% +2.7% +23.7% -42.2% -99.2% --
Operating Income Growth (YoY) -- -- -- -- -- -- -420.6% --
Net Income Growth (YoY) -- -- -- -- -- -- -417.1% --
EPS Growth (YoY) -- -- -- -- -- -- -365.5% --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -257.3% --
Free Cash Flow Growth (YoY) -- -- -- -- -- -- -274.0% --
5Y Revenue / Share Growth -- -- -100.0% -- -- -- -- --
5Y Net Income / Share Growth -- -- -1329.5% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -29.2% -25.7% -22.7% -23.5% -44.7% -39.0% -34.7% -31.1%
Return on Assets (ROA) -27.6% -24.9% -22.2% -23.1% -43.6% -38.1% -32.2% -29.9%
Current Ratio 19.62x 34.00x 56.82x 67.69x 46.95x 54.67x 14.80x 25.48x
Quick Ratio 19.43x 33.68x 56.43x 67.40x 46.66x 54.24x 14.74x 25.34x
Debt to Equity 0.00x 0.00x 0.00x 0.01x 0.01x 0.01x 0.01x 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0001808898) · from June 30, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:39 UTC · Open in terminal